GRAND RAPIDS, Mich. — Corewell Health in Grand Rapids is now offering a new, non-invasive therapy to treat liver cancer.

Liver CSCs, responsible for tumor initiation, metastasis, therapeutic resistance, and recurrence, exhibit heterogeneity and are characterized by various surface markers that contribute to their ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly ...

"YKL-40, in particular, shows strong precision medicine potential as a biomarker for liver cancer, supporting its use in early detection and focused monitoring in this population," the authors wrote.

Liver CSCs, responsible for tumor initiation, metastasis, therapeutic resistance, and recurrence, exhibit heterogeneity and are characterized by various surface markers that contribute to their ...

It's helped their cancer markers," said hand surgeon Dr. Eric George ... put people at higher risk for liver cancer.